Life Sciences on the Rise: 2021 North American Report

PUBLIC & PRIVATE FUNDING (2020-2021)

COMPANY

DEAL TYPE

COMPLETED TYPE

$ RAISED (MM)

Jaguar Gene Therapy

Early Stage

Apr 2021

VC

$139.0

Nature’s FYND

Later Stage

Mar 2020 VC

$80.0

PharmaCann

Later Stage

Mar 2021

VC

$68.0

Emalex Biosciences

Later Stage

Mar 2021

VC

$35.0

Aptinyx

Public Investment 2nd Offering

Jan 2020 Public

$30.5

CiRC Biosciences

Angel (individual)

Dec 2020 VC

$16.8

RENT VS. VACANCY COMPARISON

NNN Rents

Vacancy Rate

$35.00

16.0%

14.0%

$30.00

12.0%

$25.00

10.0%

Vacancy Rate

$20.00

8.0%

6.0%

$15.00

NNN Rent $/sf

4.0%

$10.00

2.0%

$5.00

0.0%

2015

2016

2017

2018

2019

2020

Rents not tracked prior to 2019 Source: CoStar, Cushman & Wakefield Research

REPRESENTATIVE INVESTMENT SALE TRANSACTIONS (2019-2021)

ADDRESS

TYPE

$ MM RBA SF

DATE

BUYER

1 Takeda Parkway, Deerfield, IL

Office

$115.0 660,000 Feb 2020 Horizon Therapeutics

REPRESENTATIVE LEASE TRANSACTIONS (2020)

COMPANY

ADDRESS

SUBMARKET SIZE (SF) NEW/RENEWAL TYPE QUARTER LANDLORD

CBRE Global Investors

Abbott

605 Tri-State Pky Lake County 255,272 New

Industrial Q2

Bridge Development Partners

Abbott Molecular

1015 W Devon Ave O’Hare

245,624 New

Industrial Q4

Portal Innovations 400 N Aberdeen St Fulton Market 35,000 New

Lab

Q4

Trammell Crow

Evozyne

2430 N Halsted St Lincoln Park 30,087 New

Lab

Q3

Sterling Bay

Exicure

2430 N Halsted St Lincoln Park 30,085 New

Lab

Q1

Sterling Bay

Abbott Molecular

1350 E Touhy Ave O’Hare

23,543 New

Office Q4

Marc Realty

Xeris Pharmaceuticals

1375 W Fulton Ave Fulton Market 11,782

New

Lab

Q3

Trammell Crow

Portal Innovations 1375 W Fulton Ave Fulton Market 11,000 New

Lab

Q4

Trammell Crow

/ 23

Contributor: Linsey Smith, linsey.smith@cushwake.com